Solventum (NYSE:SOLV) Updates FY 2025 Earnings Guidance

Solventum (NYSE:SOLV) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 5.450-5.650 for the period, compared to the consensus earnings per share estimate of 5.490. The company issued revenue guidance of -.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. Wells Fargo & Company lifted their price target on shares of Solventum from $73.00 to $75.00 and gave the company an “equal weight” rating in a research note on Friday. Mizuho began coverage on shares of Solventum in a report on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 price objective on the stock. Morgan Stanley lifted their price objective on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a report on Monday, November 11th. Piper Sandler lifted their price objective on shares of Solventum from $75.00 to $84.00 and gave the company a “neutral” rating in a report on Friday. Finally, Bank of America lifted their price objective on shares of Solventum from $80.00 to $85.00 and gave the company a “neutral” rating in a report on Wednesday. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $74.71.

Solventum Price Performance

Shares of SOLV opened at $79.56 on Friday. The company has a market cap of $13.74 billion and a price-to-earnings ratio of 28.93. Solventum has a 1-year low of $47.16 and a 1-year high of $96.05. The company’s fifty day simple moving average is $72.51 and its 200 day simple moving average is $69.88. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.